These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23433541)

  • 61. Glucokinase (GCK) mutations and their characterization in MODY2 children of southern Italy.
    Capuano M; Garcia-Herrero CM; Tinto N; Carluccio C; Capobianco V; Coto I; Cola A; Iafusco D; Franzese A; Zagari A; Navas MA; Sacchetti L
    PLoS One; 2012; 7(6):e38906. PubMed ID: 22761713
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Glucokinase MODY and implications for treatment goals of common forms of diabetes.
    Ajjan RA; Owen KR
    Curr Diab Rep; 2014 Dec; 14(12):559. PubMed ID: 25344793
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Population-based estimates for double diabetes amongst people with glucokinase monogenic diabetes, GCK-MODY.
    Fendler W; Małachowska B; Baranowska-Jazwiecka A; Borowiec M; Wyka K; Malecki MT; Jarosz-Chobot P; Mysliwiec M; Mlynarski W;
    Diabet Med; 2014 Jul; 31(7):881-3. PubMed ID: 24660669
    [No Abstract]   [Full Text] [Related]  

  • 64. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations.
    Singh R; Pearson ER; Clark PM; Hattersley AT
    Diabetologia; 2007 Mar; 50(3):620-4. PubMed ID: 17216282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of glucokinase gene defects in non-obese Japanese children diagnosed with diabetes by school medical examinations.
    Yokota I; Moritani M; Nishisho K; Miyoshi T; Kotani Y; Kagami S
    Endocr J; 2011; 58(9):741-6. PubMed ID: 21720051
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY.
    Steele AM; Tribble ND; Caswell R; Wensley KJ; Hattersley AT; Gloyn AL; Ellard S
    Diabetologia; 2011 Aug; 54(8):2202-5. PubMed ID: 21604084
    [No Abstract]   [Full Text] [Related]  

  • 67. Non-sense mutation of glucokinase gene.
    Froguel P; Velho G
    Lancet; 1993 Feb; 341(8841):385. PubMed ID: 8094163
    [No Abstract]   [Full Text] [Related]  

  • 68. Glucokinase and MODY: from the gene to the disease.
    Froguel P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S96-7. PubMed ID: 8894491
    [No Abstract]   [Full Text] [Related]  

  • 69. Prevalence of GCK mutations in individuals screened for fasting hyperglycaemia.
    Gloyn AL; van de Bunt M; Stratton IM; Lonie L; Tucker L; Ellard S; Holman RR
    Diabetologia; 2009 Jan; 52(1):172-4. PubMed ID: 19002431
    [No Abstract]   [Full Text] [Related]  

  • 70. Monogenic diabetes: implications for therapy of rare types of disease.
    Malecki MT; Mlynarski W
    Diabetes Obes Metab; 2008 Aug; 10(8):607-16. PubMed ID: 17488343
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Symposium on gene abnormalities in medical diseases. 2. Genetic defects and diabetes mellitus-defects of glucokinase gene and mitochondrial gene in diabetic patients.
    Oka Y
    Intern Med; 1997 Feb; 36(2):150-1. PubMed ID: 9099607
    [No Abstract]   [Full Text] [Related]  

  • 72. Glucokinase gene mutation linked to early-onset NIDDM.
    Roberts SS
    Diabetes Care; 1992 Aug; 15(8):1108-9. PubMed ID: 1505321
    [No Abstract]   [Full Text] [Related]  

  • 73. Are glucokinase mutations associated with low triglycerides?
    Berger M; Mönks D; Schmidt H; Krane V; Wanner C; Walter U; Lindner TH
    Clin Chem; 2005 Apr; 51(4):791-3. PubMed ID: 15788789
    [No Abstract]   [Full Text] [Related]  

  • 74. A novel heterozygous mutation in the glucokinase gene conferring exercise-induced symptomatic hyperglycaemia responsive to sulfonylurea.
    Ebrahim MS; Lawson ML; Geraghty MT
    Diabetes Metab; 2014 Sep; 40(4):310-3. PubMed ID: 24503189
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Glucokinase-defective NIDDM.
    Katagiri H; Asano T; Yamanouchi T; Yazaki Y; Oka Y
    Lancet; 1993 Apr; 341(8850):961-2. PubMed ID: 8096296
    [No Abstract]   [Full Text] [Related]  

  • 76. Prevalence of maturity-onset diabetes of the young mutations in Brazilian families with autosomal-dominant early-onset type 2 diabetes.
    Moises RS; Reis AF; Morel V; Chacra AR; Dib SA; Bellanne-Chantelot C; Velho G
    Diabetes Care; 2001 Apr; 24(4):786-8. PubMed ID: 11315851
    [No Abstract]   [Full Text] [Related]  

  • 77. MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of "neonatal diabetes"?
    Prisco F; Iafusco D; Franzese A; Sulli N; Barbetti F
    Diabetologia; 2000 Oct; 43(10):1331-2. PubMed ID: 11079754
    [No Abstract]   [Full Text] [Related]  

  • 78. Complete glucokinase deficiency is not a common cause of permanent neonatal diabetes.
    Gloyn AL; Ellard S; Shield JP; Temple IK; Mackay DJ; Polak M; Barrett T; Hattersley AT
    Diabetologia; 2002 Feb; 45(2):290. PubMed ID: 11942315
    [No Abstract]   [Full Text] [Related]  

  • 79. A novel heterozygous deletion in the intron 8-exon 9 boundary of the glucokinase gene in a Chinese pedigree of GCK-MODY.
    Chen M; Liang H; Zhou W; Li C; Weng J
    Acta Diabetol; 2017 Aug; 54(8):799-802. PubMed ID: 28451822
    [No Abstract]   [Full Text] [Related]  

  • 80. Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes.
    Kousta E; Ellard S; Allen LI; Saker PJ; Huxtable SJ; Hattersley AT; McCarthy MI
    Diabet Med; 2001 Aug; 18(8):683-4. PubMed ID: 11553210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.